InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)
| 1.10 Delayed Data As of Jan 15 |  +0.2213 / +25.33%Today’s Change | 0.50 Today|||52-Week Range 10.95 | +35.19% Year-to-Date |
Latest NVIV News | Press Releases
No recent news for InVivo Therapeutics Holdings Corp.
Today’s Trading
| Previous close | 0.87 |
| Today’s open | 0.89 |
| Day’s range | 0.87 - 1.15 |
| Volume | 497,416 |
| Average volume (3 months) | 2,488,850 |
| Market cap | $23.5M |
Data as of 5:53pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | +74.95% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNCASeneca Biopharma Inc | -0.05 | -3.99% |
| ---- | ||
| EARSAuris Medical Holdin... | -0.19 | -6.74% |
| HMTXDHemostemix Inc | -0.00 | -0.91% |
Data as of 3:59pm ET, 01/15/2021
Financials
| Last reporting date | February 28, 2020 |
| EPS forecast (this quarter) | -$9.00 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$11.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
